Figure 2.
Association of TXNIP expression with patient clinicopathological characteristics. (A) T stage. (B) Lymph-node status. (C) Clinical stage. (D) Grade. (E) Effect of TXNIP expression on the overall survival of patients with CCRCC in The Cancer Genome Atlas datasets. TXNIP, thioredoxin interacting protein; CCRCC, clear cell renal cell carcinoma. *P<0.05 and ***P<0.001.